Among others, eotaxin was prominently affected compared to placebo controls but failed to reach significance, which might hint at previous findings that revacept did not reduce the bleeding risk after PCI [ 14 ].
← all excerpts
Plasma chemokines indicate enhanced bleeding in patients with chronic coronary syndrome undergoing percutaneous coronary stenting.
1
—
—